These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 956991)

  • 1. Letter: Prenatal screening for erythroblastosis fetalis.
    Austin TK; Myhre B; Hana C
    J Pediatr; 1976 Sep; 89(3):519-20. PubMed ID: 956991
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of screening test for irregular antibodies].
    Nagao N
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():728-33. PubMed ID: 20942175
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differential diagnosis of erythroblastosis fetalis].
    SEELEMANN K
    Z Kinderheilkd; 1952; 71(1):61-78. PubMed ID: 12995816
    [No Abstract]   [Full Text] [Related]  

  • 4. Fetal blood group studies during mid-trimester pregnancy and the management of severe isoimmunization.
    MacKenzie I; Guest CM; Bowell PJ
    Prenat Diagn; 1983 Jan; 3(1):41-6. PubMed ID: 6601799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and roentgen manifestations of erythroblastosis fetalis.
    RITVO M; SHAUFFER IA; KROSNICK G
    Am J Roentgenol Radium Ther; 1949 Mar; 61(1):291-301. PubMed ID: 18114629
    [No Abstract]   [Full Text] [Related]  

  • 6. [Differential diagnosis of erythroblastosis fetalis].
    DE GAVALLER B
    Rev Obstet Ginecol Venez; 1955; 15(1):405-23. PubMed ID: 13255303
    [No Abstract]   [Full Text] [Related]  

  • 7. [The A and B group-specific substances in the diagnosis of ABO materno-fetal isoimmunization].
    POZZI V; RUSSO R
    Clin Ostet Ginecol; 1961 Dec; 63():627-32. PubMed ID: 14488427
    [No Abstract]   [Full Text] [Related]  

  • 8. [Further studies on the immunology of the A group substance].
    PROKOP O; SCHLEYER F
    Schweiz Z Pathol Bakteriol; 1952; 15(1):15-9. PubMed ID: 14942451
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythroblastosis fetalis: identification, management, and prevention.
    Frigoletto FD; Umansky I
    Clin Perinatol; 1979 Sep; 6(2):321-30. PubMed ID: 117965
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical value of serologic examinations related to blood groups in pregnant patients.
    STERN K
    Am J Obstet Gynecol; 1958 Feb; 75(2):369-75. PubMed ID: 13498082
    [No Abstract]   [Full Text] [Related]  

  • 11. Ante-natal prediction of ABO haemolytic disease.
    TOVEY GH; LOCKYER JW; BLADES AN; FLAVELL HC
    Br J Haematol; 1962 Jul; 8():251-7. PubMed ID: 13922188
    [No Abstract]   [Full Text] [Related]  

  • 12. [Isoimmunization by the factors of group A and B. Serological study of the ABO antagonism. Bases for detecting it?].
    BRICOULT A
    Brux Med; 1960 Mar; 40():329-38. PubMed ID: 13804373
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac output in a fetus with erythroblastosis fetalis: assessment using pulsed Doppler.
    Barss VA; Doubilet PM; St John-Sutton M; Cartier MS; Frigoletto FD
    Obstet Gynecol; 1987 Sep; 70(3 Pt 2):442-4. PubMed ID: 3306505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Roentgenological picture of fetal hydrops].
    VALENTA M
    Cesk Rentgenol; 1955 Jun; 9(2):49-56. PubMed ID: 13261283
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the radiological diagnosis of hydrops foetalis in utero.
    ENGSTROM L; FORSBERG A
    Acta Obstet Gynecol Scand; 1958; 37(3):298-302. PubMed ID: 13594325
    [No Abstract]   [Full Text] [Related]  

  • 16. ABO hemolytic disease. Serologic diagnosis with the two stage direct antiglobulin test, by means of fresh serum.
    CHAN AC; CHUNG F; KEITEL HG
    J Pediatr; 1962 Sep; 61():405-12. PubMed ID: 13877997
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prediction of fetal blood group from amniotic fluid and use in hemolytic disease of the newborn (author's transl)].
    Qian ML
    Zhonghua Fu Chan Ke Za Zhi; 1982 Jan; 17(1):21-3. PubMed ID: 6807636
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of the occurrence of erythroblastosis fetalis by antenatal Rh testing and its treatment by complete exchange transfusion.
    WIENER AS
    Pittsbg Med Bull; 1946 Nov; 35(39):778-86. PubMed ID: 20281084
    [No Abstract]   [Full Text] [Related]  

  • 19. [Improved intrauterine diagnosis and therapy of blood group incompatibility].
    Brusis E; Gloning KP; Schramm T; Ostermayer E; Kuss E
    Gynakol Rundsch; 1989; 29 Suppl 2():256-9. PubMed ID: 2482232
    [No Abstract]   [Full Text] [Related]  

  • 20. [Perinatal research on feto-maternal anti-Kell immunization].
    Gavriil P; Jauniaux E; Lambermont M; Donner C; Avni FE; Rodesch F
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(6):761-4. PubMed ID: 2689503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.